Z. Tian

发表

Targeting the CXCR4–CXCL12 Axis Mobilizes Autologous Hematopoietic Stem Cells and Prolongs Islet Allograft Survival via Programmed Death Ligand 1

S. Rodig, R. Abdi, M. Jurewicz, 2011, The Journal of Immunology.

Dulxanthone A induces cell cycle arrest and apoptosis via up‐regulation of p53 through mitochondrial pathway in HepG2 cells

Annie P. Moseman, I. Kohane, Jie Shen, 2008, International journal of cancer.

Cytotoxic diarylheptanoid induces cell cycle arrest and apoptosis via increasing ATF3 and stabilizing p53 in SH-SY5Y cells

I. Kohane, P. Xiao, E. Wu, 2009, Cancer Chemotherapy and Pharmacology.

Comprehensive Dissection of PDGF-PDGFR Signaling Pathways in PDGFR Genetically Defined Cells

Isaac S. Kohane, Michal Galdzicki, Ze Tian, 2008, PloS one.

Diarylheptanoids from the rhizomes of Alpinia officinarum and their anticancer activity.

Z. Tian, Z. Zou, Xiu-zhen Luo, 2008, Fitoterapia.

Antitumor activity and mechanisms of action of total glycosides from aerial part of Cimicifuga dahurica targeted against hepatoma

Qi Chang, P. Xiao, Shilin Chen, 2007, BMC Cancer.

A Practical Platform for Blood Biomarker Study by Using Global Gene Expression Profiling of Peripheral Whole Blood

Isaac S. Kohane, Patrick R. Schmid, Michal Galdzicki, 2009, PloS one.

Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes

J. Bluestone, S. Rodig, R. Abdi, 2008, Diabetes.

TIM4 Regulates the Anti-Islet Th2 Alloimmune Response

J. Markmann, A. Secchi, L. Turka, 2015, Cell transplantation.

The cytotoxicity of naturally occurring styryl lactones.

P. Xiao, Mengsu Yang, Z. Tian, 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

This information is current as via Programmed Death Ligand 1 Cells and Prolongs Islet Allograft Survival Mobilizes Autologous Hematopoietic Stem CXCL12 Axis - Targeting the CXCR4

S. Rodig, R. Abdi, M. Jurewicz, 2012 .

A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib

R. Coffman, K. Anderson, P. Richardson, 2014, Leukemia.

ERK1/2 contributes negative regulation to STAT3 activity in HSS-transfected HepG2 cells

W. An, Z. Tian, 2004, Cell Research.

A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.

Parantu K. Shah, N. Munshi, P. Richardson, 2012, Cancer cell.

Cytotoxic Activity of Schisandrolic and Isoschisandrolic Acids Involves Induction of Apoptosis

Lijia Xu, P. Xiao, Mengsu Yang, 2007, Chemotherapy.

Cytotoxicity of three cycloartane triterpenoids from Cimicifuga dahurica.

P. Xiao, Mengsu Yang, Z. Tian, 2005, Cancer letters.

Chemical constituents from the fruits of Hippophae rhamnoides

Z. Tian, Xu-dong Xu, Jun-shan Yang, 2009, Natural product research.

Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells.

Jian-jun Zhao, P. Richardson, A. Berger, 2012, Blood.

In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells

P. Richardson, D. Kuhn, R. Orlowski, 2011, Clinical Cancer Research.

Cytotoxicity of two triterpenoids from Nigella glandulifera.

P. Xiao, E. Wu, Z. Tian, 2006, Molecules.

Cimicifuga foetida extract inhibits proliferation of hepatocellular cells via induction of cell cycle arrest and apoptosis.

R. Pan, Qi Chang, P. Xiao, 2007, Journal of ethnopharmacology.

Cytotoxicity of cycloartane triterpenoids from aerial part of Cimicifuga foetida.

P. Xiao, R. Pan, Z. Tian, 2006, Fitoterapia.

Anti-hepatoma activity and mechanism of ursolic acid and its derivatives isolated from Aralia decaisneana.

P. Xiao, Z. Tian, Feng-jiao Huang, 2006, World journal of gastroenterology.

Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer

S. Davis, R. Smallridge, Zhuyin Li, 2015, Oncotarget.

Cambogin Is Preferentially Cytotoxic to Cells Expressing PDGFR

I. Kohane, Jie Shen, A. Kazlauskas, 2011, PloS one.

Preclinical Activity of the Oral Proteasome Inhibitor MLN9708 in Myeloma Bone Disease

A. Berger, D. Chauhan, N. Raje, 2014, Clinical Cancer Research.

Anti-cancer activity and mechanisms of 25-anhydrocimigenol-3-O-&bgr;-D-xylopyranoside isolated from Souliea vaginata on hepatomas

P. Xiao, Mengsu Yang, E. Wu, 2006, Anti-cancer drugs.

A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance.

P. Richardson, Yiguo Hu, D. Chauhan, 2014, Blood.

Cancer Therapy: Preclinical In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells

P. Richardson, D. Kuhn, R. Orlowski, 2011 .

In vitro and In vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN 9708 Against Multiple Myeloma Cells

P. Richardson, D. Kuhn, R. Orlowski, 2011 .

Cancer Therapy : Preclinical In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN 9708 against Multiple Myeloma Cells

P. Richardson, D. Kuhn, R. Orlowski, 2011 .

Cancer Therapy : Preclinical Preclinical Activity of theOral Proteasome InhibitorMLN 9708 in Myeloma Bone Disease

A. Berger, D. Chauhan, N. Raje, 2014 .

Different contributions of STAT3, ERK1/2, and PI3-K signaling to cardiomyocyte hypertrophy by cardiotrophin-1.

Hui Zhang, Li Chen, W. An, 2004, Acta pharmacologica Sinica.

Crosstalk between ERK1/2 and STAT3 in the modulation of cardiomyocyte hypertrophy induced by cardiotrophin-1.

Hui Zhang, Li Chen, W. An, 2004, Chinese medical journal.

Anti-Myeloma Activity of a Novel Free Radical Inducer Rrx-001

P. Richardson, D. Chauhan, Z. Tian, 2014 .

Different contributions of STAT 3 , ERK 1 / 2 , and PI 3K signaling to cardiomyocyte hypertrophy by cardiotrophin-11

Hui Zhang, Li Chen, Z. Tian, 2004 .

CSN5 promotes carcinogenesis of thyroid carcinoma cells through ANGPTL2.

Yue Liu, Z. Tian, Jichun Yu, 2020, Endocrinology.

Deubiquitylating Enzyme USP-7, a Novel Therapeutic Target in Multiple Myeloma.

N. Munshi, P. Richardson, D. Chauhan, 2009 .

Abstract C94: Deubiquitylases as novel anticancer targets: Discovery and development of novel USP7 inhibitors

D. Chauhan, P. Cao, K. G. S. Kumar, 2009 .

A novel rapid-onset high-penetrance plasmacytoma mouse model driven by deregulation of cMYC cooperating with KRAS12V in BALB/c mice

K. Anderson, N. Munshi, G. Görgün, 2013, Blood Cancer Journal.

In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells

P. Richardson, D. Kuhn, R. Orlowski, 2011, Clinical Cancer Research.